However, expression of GNB2L1 was completely suppressed in the destination cells of lineage 2, but significantly increased during the development of lineage 1, thereby indicating that lineage 2 development might potentially confer MPS-I NB cells with chemotherapy resistance. This evidence concerns the gene RACK1 and neuroblastoma.